Early Stage Researcher 8

Novel immunoassays for Alzheimer's disease

The goal of the project is to develop novel immunoassays to improve the diagnosis of Alzheimer’s Disease.


Your main tasks and responsibilities in this project will be:

  • to develop customized panels of immunoassays for analysis of novel biomarker candidates;
  • to optimize these panels for biomarker detection in both CSF and blood using state of the art technologies, such as enzyme-linked immunosorbent assays (ELISA) or single molecule arrays;
  • to technically and clinically validate novel tests in relevant patient samples from different cohorts;
  • to process and to analyse the data;
  • to communicate results by means of oral presentations and scientific publications;
  • to perform one secondment (internship) of n. 6 (six) months at the Quanterix Corporation (US), to apply an ultrasensitive Simoa blood-based assay.


We look for excellent candidates with a M.Sc. degree in Biology, Biotechnology, Biochemistry, Chemistry or related fields.


The Host Institution of the project is: University of Perugia, Italy.

As an early stage researcher you will work in the stimulating environment of the Laboratory of Clinical Neurochemistry, Section of Neurological Clinic - Department of Medicine of the University of Perugia, headed by Prof. Lucilla Parnetti, in collaboration with the postdocs Dr. Silvia Paciotti and Dr. Samuela Cataldi. You will be part of a multidisciplinary team, with experience in the field of biomarker clinical validation.


For more information about this position and application procedure, you can contact Prof. Lucilla Parnetti, e-mail: laboratorio.neurochimica-clinica@unipg.it.

Link to vacancy on institutional website and Euraxess